Amaninder S. Toor

Amaninder Toor practices at UPMC Mercy in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center.

Amaninder Toor's NPI, 1760613806, was assigned on August 6, 2009. Amaninder Toor holds Pennsylvania license MD446083.

Amaninder Toor's primary practice is UPMC Mercy, at 1400 Locust Street, Pittsburgh, PA 15219 in Allegheny County. The practice phone is (412) 232-8111.

Amaninder Toor's primary practice is UPMC Mercy in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center. Amaninder Toor is also affiliated with UPMC Passavant-McCandless. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Amaninder Toor to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Amaninder Toor practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Amaninder Toor's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Amaninder Toor is licensed in Pennsylvania.

CMS data shows 451 Medicare services from Amaninder Toor across 3 procedure codes in 2024, for 231 Medicare patients. Medicare paid $27,479 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 231 Medicare patients who saw Amaninder Toor in 2024. The largest group is 65 to 74, with 88 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 2.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Amaninder Toor's median patient age at 75, with 50% women.

In 2024, Amaninder Toor wrote 182 Medicare Part D claims for 71 patients. 85% of them were for generic drugs. CMS names the drug for 32 of them, across 2 drugs with 11 or more claims each, at $6,312 in total drug cost. In 2023, CMS named 24 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Amaninder Toor for performance year 2024, reported through an alternative payment model (APM). Amaninder Toor accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 29 general payments to Amaninder Toor from 11 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $612.